Atlas Trials

Ketamine Treatment for Pediatric-Refractory Obsessive-Compulsive Disorder (OCD)

Clinical trial NCT02422290 · COMPLETED

Trial details

NCT number
NCT02422290
Sponsor
New York State Psychiatric Institute
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Obsessive-Compulsive Disorder
Start date
2015-03-01
Primary completion
2018-02-21
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.